By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 116.78 |
Closing Price Change | $ 3.20 |
% Change | 0.00 % |
52 Week High | $0.00 |
52 Week Low | $0.00 |
Volume | 0 |
Shares Issued | 1,246.00m |
RiskGrade | 120 |
Time | Volume / Share Price |
10:25 | 125 @ $116.60 |
10:25 | 215 @ $116.63 |
10:25 | 100 @ $116.61 |
10:25 | 100 @ $116.61 |
10:25 | 100 @ $116.59 |
You are here: research